Conversion Strategy in Left-Sided RAS/BRAF Wild-Type Metastatic Colorectal Cancer Patients with Unresectable Liver-Limited Disease: A Multicenter Cohort Study

SIMPLE SUMMARY: Around 70% of patients suffering from colorectal cancer (CRC) develop liver metastases. In the present multicentric cohort study, we explored the efficacy of a conversion strategy in a selected population of 272 left-sided RAS/BRAF wild-type CRC patients with liver-limited metastatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Granieri, Stefano, Cotsoglou, Christian, Bonomi, Alessandro, Salvatore, Lisa, Filippi, Roberto, Nigro, Olga, Gelsomino, Fabio, Zurlo, Ina Valeria, Depetris, Ilaria, Giampieri, Riccardo, Berardi, Rossana, Morelli, Cristina, De Tursi, Michele, Roberto, Michela, Gjoni, Elson, Germini, Alessandro, de Angelis, Nicola, Memeo, Riccardo, Facciorusso, Antonio, Garrone, Ornella, Ramai, Daryl, Ghidini, Michele, Parisi, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688791/
https://www.ncbi.nlm.nih.gov/pubmed/36428606
http://dx.doi.org/10.3390/cancers14225513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688791/
https://www.ncbi.nlm.nih.gov/pubmed/36428606
http://dx.doi.org/10.3390/cancers14225513

Ejemplares similares